- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.12.25 | Beta Bionics, Inc.: Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 | 1 | GlobeNewswire (USA) | ||
| 29.10.25 | Beta Bionics raises 2025 revenue guidance to $96.5M and projects Q4 gross margin improvement amid pharmacy channel expansion | 1 | Seeking Alpha | ||
| 28.10.25 | Beta Bionics, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 28.10.25 | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | 1.045 | GlobeNewswire (Europe) | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| 28.10.25 | Beta Bionics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| BETA BIONICS Aktie jetzt für 0€ handeln | |||||
| 20.10.25 | Stifel resumes Beta Bionics stock coverage with Buy rating on iLet adoption | 1 | Investing.com | ||
| 20.10.25 | Stifel: Kaufempfehlung für Beta Bionics dank starker iLet-Marktakzeptanz | 3 | Investing.com Deutsch | ||
| 17.10.25 | Beta Bionics stock reaffirmed Buy at Truist Securities on strong growth outlook | 1 | Investing.com | ||
| 09.10.25 | Beta Bionics, Inc.: Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025 | 2 | GlobeNewswire (USA) | ||
| 01.10.25 | Forecasting The Future: 4 Analyst Projections For Beta Bionics | 1 | Benzinga.com | ||
| 01.10.25 | Wachstum bei Diabetestechnologie: Goldman Sachs stuft Beta Bionics auf "Buy" hoch | 6 | Investing.com Deutsch | ||
| 01.10.25 | Goldman Sachs upgrades Beta Bionics stock to Buy on diabetes tech growth | 2 | Investing.com | ||
| 30.07.25 | Beyond The Numbers: 6 Analysts Discuss Beta Bionics Stock | 2 | Benzinga.com | ||
| 30.07.25 | Beta Bionics stock price target raised to $21 by Truist on strong revenue | 2 | Investing.com | ||
| 29.07.25 | Beta Bionics GAAP EPS of -$0.39 beats by $0.08, revenue of $23.2M beats by $3.51M | 14 | Seeking Alpha | ||
| 29.07.25 | Beta Bionics Q2 2025 presentation: Revenue soars to $23.2M, guidance raised | 1 | Investing.com | ||
| 29.07.25 | Beta Bionics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 29.07.25 | Beta Bionics, Inc.: Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | 838 | GlobeNewswire (Europe) | IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| 19.06.25 | Beta Bionics, Inc.: Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor | 437 | GlobeNewswire (Europe) | IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet... ► Artikel lesen | |
| 06.05.25 | Beta Bionics, Inc.: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 | 646 | GlobeNewswire (Europe) | IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results... ► Artikel lesen |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 15,010 | -1,64 % | ECKERT & ZIEGLER SE - Stabilität als strategische Basis | ||
| HIMS & HERS HEALTH | 28,740 | +0,74 % | HIMS Stock On A Losing Spree: Here's Why | ||
| RADNET | 60,50 | -0,82 % | RadNet, Inc.: GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning | Collaboration aims to expand existing U.S. relationship combining GE HealthCare's mammography systems with DeepHealth's Breast Suite to include a worldwide distribution arrangementIntends to integrate... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 30,760 | -2,22 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 38,400 | +2,54 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| INFUSYSTEM | 7,350 | -0,68 % | InfuSystem Holdings, Inc - 8-K, Current Report | ||
| IRADIMED | 84,00 | +1,82 % | Insider Unloading: Roger E Susi Sells $488K Worth Of iRadimed Shares | ||
| KESTRA MEDICAL TECHNOLOGIES | 24,360 | -8,14 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Second Quarter Fiscal 2026 Financial Results | KIRKLAND, Wash., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,140 | -1,74 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,170 | -1,45 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,730 | -2,55 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| GENEDX | 132,30 | +1,72 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,740 | +0,23 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,225 | +2,41 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 39,620 | -0,95 % | CARL ZEISS MEDITEC AG: Ruhe vor dem nächsten Takt |
Das Unternehmen BETA BIONICS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 29,250 Euro und damit -4,00 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BETA BIONICS INC finden Sie auf Wallstreet Online.